Archives: Agenda

SPOTLIGHT – Innovation in Rare Disease

  • Analysis of Real World (Audit) Data in driving drug discovery
  • Use of RWD in driving drug discovery in rare diseases
  • Leveraging therapeutics for rare disease to larger, multiple global applications

PATIENT SPOTLIGHT Upstream Recruitment: Why Representation Is Decided Long Before Consent

Despite increased focus on diversity in clinical trials, under-representation of marginalised communities persists. Recruitment is often viewed as a downstream operational task focused on screening and enrolment.

This session introduces the concept of upstream recruitment the social, structural and relational factors that determine whether individuals ever encounter clinical research. Drawing on lived experience and a health equity lens, the discussion explores how trust in healthcare systems, access to trial sites, language, historic harm and time or financial burden shape participation.

The session will equip attendees with practical insight into how trust, access and structural barriers influence participation and what this means for designing more inclusive clinical trials.

Applying AI Tools Effectively in Clinical Trials

  • Leveraging AI tools to optimize patient recruitment, site selection, and trial feasibility.
  • Using AI for real-time data monitoring, quality checks, and endpoint analysis.
  • Integrating AI solutions seamlessly into trial workflows to support operational efficiency.
  • Ensuring regulatory compliance, validation, and transparency when deploying AI in active studies.